Search the web
Sign In
New User? Sign Up
experimentalandunconventional · Experimental and Unconventional - New Therapies for Colon Cancer
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Want to share photos of your group with the world? Add a group photo to Flickr.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
18 times Bevacizumab (Avastin)   Message List  
Reply | Forward Message #1358 of 1454 |
I am from the Netherlands. Colon cancer (Dukes IV) was discovered in
Febr. 2006.
I was treated with Oxaliplatin (4 months), Capecitabine (Xeloda) 6
months, and 18 times with Bevacizumab (Avastin) during 57 months.
De growth of the tumor and the metastasen has allready stopped for
about one year, but it is still there in reduced form in the colon and
in the liver. The last months I got problems with peripheral neuropathy
so that the hospital also stopped with the Avastin.
Has anyone the same experience. What can be done about the neuropathy.
My oncoloog gives me medicines but they do not help much. I would like
to hear from anyone simular or other experience and perhaps also a
solution for the neuropathy. May the Lord bless you all.




Thu May 24, 2007 5:57 pm

maartenaleman
Offline Offline
Send Email Send Email

Forward
Message #1358 of 1454 |
Expand Messages Author Sort by Date

I am from the Netherlands. Colon cancer (Dukes IV) was discovered in Febr. 2006. I was treated with Oxaliplatin (4 months), Capecitabine (Xeloda) 6 months, and...
maartenaleman
Offline Send Email
May 24, 2007
5:59 pm

Welcome to the group, though I'm sorry you have to be here. I had Xeloda, 6000 milligrams a day when I took it, and had serious hand and foot syndrome, got ...
Denise Dawson
mystc1celt
Offline Send Email
May 24, 2007
6:31 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help